Fate Therapeutics, Inc.FATENASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P14
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
2 yr
Consecutive growthDecelerating
| Period | Value |
|---|---|
| 2025 | -20.13% |
| 2024 | -21.78% |
| 2023 | -46.14% |
| 2022 | 48.69% |
| 2021 | 71.56% |
| 2020 | 43.13% |
| 2019 | 56.67% |
| 2018 | 63.06% |
| 2017 | 29.89% |
| 2016 | 33.19% |